9 completed, 1 unknown. 10 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 9, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Creatine monohydrate: new trials by email Literature Review of Creatine monohydrate trials Research Report on Creatine monohydrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 5-HTP and Creatine for Depression 5-Hydroxytryptophan 100 MG, Creatine monohydrate, placebo matched to 5-HTP - Major Depressive Disorder | Phase 2 | Completed | University of Utah | 43 | 2021-03-01 | 2024-07-23 |
| Creatine Use and Muscle Stretching in Peripheral Artery Disease Creatine monohydrate, Cellulose - Peripheral Arterial Disease | Phase 2 | Completed | Florida State University | 13 | 2020-05-12 | 2025-12-08 |
| Effects of High-velocity Resistance Training and Creatine Supplementation in Healthy Aging Males Creatine monohydrate, Maltodextrin Powder - Sarcopenia | Phase 2 | Unknown | University of Regina | 40 | 2018-01-01 | 2018-05-21 |
| Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability Creatine monohydrate - Huntington's Disease | Phase 2 | Completed | Massachusetts General Hospital | 24 | 2010-04-01 | 2014-02-10 |
| Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study Creatine Monohydrate - Huntington's Disease | Phase 2 | Completed | Massachusetts General Hospital | 38 | 2009-05-01 | 2014-02-10 |
| Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram Creatine Monohydrate - Major Depressive Disorder | Phase 2 | Completed | University of Utah | 13 | 2009-04-01 | 2017-05-12 |
| Creatine Safety and Tolerability in Premanifest HD: PRECREST Creatine monohydrate, Placebo - Huntington Disease | Phase 2 | Completed | Massachusetts General Hospital | 64 | 2007-12-01 | 2014-02-10 |
| Creatine Safety & Tolerability in Huntington's Disease Creatine monohydrate - Huntington's Disease (HD) | Phase 2 | Completed | Massachusetts General Hospital | 10 | 2005-04-01 | 2018-03-09 |
| Creatine for the Treatment of Amyotrophic Lateral Sclerosis creatine monohydrate - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 110 | 2002-12-01 | 2006-08-04 |
| Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy Creatine Monohydrate, Glutamine - Muscular Dystrophy, Duchenne | Phase 2 / Phase 3 | Completed | Cooperative International Neuromuscular Research Group | 48 | 2000-06-01 | 2011-10-27 |
Huntington Disease (4) · Depressive Disorder, Major (2) · Amyotrophic Lateral Sclerosis (1) · Depression (1) · Muscular Dystrophy, Duchenne (1) · Peripheral Arterial Disease (1) · Sarcopenia (1)
Massachusetts General Hospital (4) · University of Utah (2) · Cooperative International Neuromuscular Research Group (1) · Florida State University (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · University of Regina (1)
United States (9) · Canada (1)
Diana Rosas, MD, MS (3) · Steven M Hersch, MD, PhD (2) · Darren G Candow, PhD (1) · Diana M Escolar, MD (1) · Douglas G Kondo, MD (1) · Gunnar Buyse, MD, PhD (1) · Jeffrey Rosenfeld, MD (1) · Judy Muller-Delp, Ph.D. (1)
P01NS058793 (1)